Colinz Laboratories Limited (COLINZ.BO)
INR 52.06
(-4.07%)
INR 52.06
(-4.07%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 70.29 Million INR | -1.75% |
| 2022 | 71.54 Million INR | 2.59% |
| 2021 | 69.74 Million INR | 13.24% |
| 2020 | 61.59 Million INR | -19.0% |
| 2019 | 76.03 Million INR | -0.85% |
| 2018 | 76.68 Million INR | -2.71% |
| 2017 | 78.81 Million INR | 3.21% |
| 2016 | 76.36 Million INR | -5.67% |
| 2015 | 80.95 Million INR | 2.66% |
| 2014 | 78.85 Million INR | 6.52% |
| 2013 | 74.02 Million INR | 3.02% |
| 2012 | 71.85 Million INR | 8.85% |
| 2011 | 66.01 Million INR | 15.77% |
| 2010 | 57.02 Million INR | 1.11% |
| 2009 | 56.39 Million INR | 8.28% |
| 2008 | 52.08 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 17.46 Million INR | 7.19% |
| 2024 Q2 | 18.63 Million INR | 6.67% |
| 2023 Q2 | 17.86 Million INR | -5.96% |
| 2023 Q3 | 17.14 Million INR | -4.01% |
| 2023 FY | 70.29 Million INR | -1.75% |
| 2023 Q1 | 18.99 Million INR | 10.39% |
| 2023 Q4 | 16.29 Million INR | -4.96% |
| 2022 Q1 | 18.38 Million INR | 16.19% |
| 2022 Q3 | 16.79 Million INR | -12.36% |
| 2022 Q4 | 17.2 Million INR | 2.45% |
| 2022 FY | 71.54 Million INR | 2.59% |
| 2022 Q2 | 19.16 Million INR | 4.27% |
| 2021 FY | 69.74 Million INR | 13.24% |
| 2021 Q1 | 18.5 Million INR | 13.03% |
| 2021 Q2 | 19.5 Million INR | 5.42% |
| 2021 Q3 | 15.91 Million INR | -18.43% |
| 2021 Q4 | 15.82 Million INR | -0.58% |
| 2020 Q2 | 16.08 Million INR | 13.61% |
| 2020 Q1 | 14.15 Million INR | -14.46% |
| 2020 Q3 | 14.98 Million INR | -6.85% |
| 2020 Q4 | 16.37 Million INR | 9.28% |
| 2020 FY | 61.59 Million INR | -19.0% |
| 2019 Q1 | 20.24 Million INR | 19.82% |
| 2019 FY | 76.03 Million INR | -0.85% |
| 2019 Q4 | 16.54 Million INR | -14.29% |
| 2019 Q3 | 19.3 Million INR | -3.12% |
| 2019 Q2 | 19.93 Million INR | -1.57% |
| 2018 FY | 76.68 Million INR | -2.71% |
| 2018 Q4 | 16.89 Million INR | -10.95% |
| 2018 Q3 | 18.97 Million INR | -4.93% |
| 2018 Q2 | 19.96 Million INR | -4.27% |
| 2018 Q1 | 20.85 Million INR | 11.21% |
| 2017 FY | 78.81 Million INR | 3.21% |
| 2017 Q3 | 19.46 Million INR | -14.5% |
| 2017 Q2 | 22.77 Million INR | 22.45% |
| 2017 Q4 | 18.74 Million INR | -3.7% |
| 2017 Q1 | 18.59 Million INR | 4.38% |
| 2016 Q2 | 22.15 Million INR | -1.27% |
| 2016 Q1 | 22.44 Million INR | 22.17% |
| 2016 Q4 | 17.81 Million INR | 5.0% |
| 2016 Q3 | 16.96 Million INR | -23.41% |
| 2016 FY | 76.36 Million INR | -5.67% |
| 2015 Q4 | 18.36 Million INR | -2.44% |
| 2015 Q2 | 19.64 Million INR | -18.54% |
| 2015 Q3 | 18.82 Million INR | -4.16% |
| 2015 FY | 80.95 Million INR | 2.66% |
| 2015 Q1 | 24.11 Million INR | 41.35% |
| 2014 Q2 | 21.74 Million INR | 1.04% |
| 2014 Q1 | 21.52 Million INR | 19.72% |
| 2014 Q4 | 17.06 Million INR | -7.94% |
| 2014 FY | 78.85 Million INR | 6.52% |
| 2014 Q3 | 18.53 Million INR | -14.78% |
| 2013 Q2 | 18.45 Million INR | -4.47% |
| 2013 Q4 | 17.97 Million INR | -1.7% |
| 2013 FY | 74.02 Million INR | 3.02% |
| 2013 Q1 | 19.31 Million INR | 19.21% |
| 2013 Q3 | 18.28 Million INR | -0.89% |
| 2012 Q4 | 16.2 Million INR | 0.89% |
| 2012 Q2 | 17.89 Million INR | -17.57% |
| 2012 FY | 71.85 Million INR | 8.85% |
| 2012 Q1 | 21.7 Million INR | 85.28% |
| 2012 Q3 | 16.05 Million INR | -10.25% |
| 2011 Q3 | 16.49 Million INR | 0.0% |
| 2011 Q4 | 11.71 Million INR | -28.98% |
| 2011 FY | 66.01 Million INR | 15.77% |
| 2010 FY | 57.02 Million INR | 1.11% |
| 2009 Q4 | 11.28 Million INR | 0.0% |
| 2009 FY | 56.39 Million INR | 8.28% |
| 2008 FY | 52.08 Million INR | 0.0% |
| 2008 Q4 | 10.86 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 95.189% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 96.521% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Beryl Drugs Limited | 271.24 Million INR | 74.084% |
| Concord Drugs Limited | 449.24 Million INR | 84.352% |
| Deccan Health Care Limited | 597.28 Million INR | 88.231% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 85.347% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | 53.715% |
| Mercury Laboratories Limited | 755.59 Million INR | 90.697% |
| Panchsheel Organics Limited | 1.05 Billion INR | 93.319% |
| Parmax Pharma Limited | 154.24 Million INR | 54.425% |
| Parnax Lab Limited | 1.88 Billion INR | 96.275% |
| Patidar Buildcon Limited | 2.3 Million INR | -2945.754% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | 53.484% |
| Phaarmasia Limited | 305.93 Million INR | 77.022% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 89.552% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 99.482% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 82.436% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 74.248% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 98.484% |
| Sunil Healthcare Limited | 901.91 Million INR | 92.206% |
| Syschem (India) Limited | 2.33 Billion INR | 96.99% |
| Trident Lifeline Limited | 446.28 Million INR | 84.249% |
| Transchem Limited | 4.09 Million INR | -1614.537% |
| Tyche Industries Limited | 696.83 Million INR | 89.912% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 94.395% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 81.011% |
| Zenith Healthcare Limited | 144.71 Million INR | 51.425% |
| Zenotech Laboratories Limited | 368.08 Million INR | 80.902% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -570.154% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 93.297% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -282.418% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.875% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 86.906% |
| Smruthi Organics Limited | 1.27 Billion INR | 94.493% |
| Trimurthi Limited | 42.23 Million INR | -66.428% |
| Zenlabs Ethica Limited | 585.63 Million INR | 87.997% |
| Makers Laboratories Limited | 1.03 Billion INR | 93.225% |
| Lactose (India) Limited | 1.13 Billion INR | 93.828% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 84.242% |
| Roopa Industries Limited | 715.53 Million INR | 90.176% |
| PANJON LTD. | 125.52 Million INR | 43.997% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 98.914% |
| Crestchem Limited | 212.56 Million INR | 66.929% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -1166.138% |
| PRAVEG LIMITED | 915.96 Million INR | 92.325% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 97.981% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 90.574% |
| Norris Medicines Limited | 56.35 Million INR | -24.735% |
| Denis Chem Lab Limited | 1.67 Billion INR | 95.811% |
| Veerhealth Care Limited | 142.13 Million INR | 50.542% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 97.712% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 95.048% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 82.267% |
| Godavari Drugs Limited | 1.56 Billion INR | 95.514% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -6187.657% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 95.968% |
| Gennex Laboratories Limited | 867.14 Million INR | 91.893% |
| Vivanza Biosciences Limited | 278.89 Million INR | 74.795% |
| Medi-Caps Limited | 265.63 Million INR | 73.537% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 80.622% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 94.416% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 95.861% |
| Bharat Parenterals Limited | 2.59 Billion INR | 97.29% |
| BDH Industries Limited | 858.31 Million INR | 91.81% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | 31.671% |
| Coral Laboratories Limited | 836.6 Million INR | 91.597% |
| Evoq Remedies Limited | 63.09 Million INR | -11.422% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 93.131% |
| Cian Healthcare Limited | 616.95 Million INR | 88.606% |
| Trinity League India Limited | 2.95 Million INR | -2282.915% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 95.477% |
| Auro Laboratories Limited | 526.99 Million INR | 86.661% |